Highwoods Properties, Inc.
$7.25B- Market cap
- $3.44B
- Debt
- +$3.84B
- Cash
- −$27.36M
Capital structure 47% equity / 53% debt · EV / Revenue 8.99x · EV / EBITDA 9.53x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HIW stock price at premium vs HRMY $31.19 current versus $22.61 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HRMY's multiple
Implied fair value · at HIW's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HIW FY 2025 (ended Dec 31, 2025) · HRMY FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 47% equity / 53% debt · EV / Revenue 8.99x · EV / EBITDA 9.53x
Capital structure 94% equity / 6% debt · EV / Revenue 2.13x · EV / EBITDA 7.27x
HIW carries the larger enterprise value at $7.25B against $1.85B; HRMY trades on the lower EV / Revenue multiple (2.13x vs 8.99x); HRMY on the lower EV / EBITDA (7.27x vs 9.53x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HIGHWOODS PROPERTIES, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
HARMONY BIOSCIENCES HOLDINGS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.61x
0.19x
Net debt / EBITDA
Leverage against operating earnings
5.01x
-2.41x
Cash and equivalents
Liquid reserves on the balance sheet
$27.36M
$775.34M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BXP, Inc.
HIW vs BXP
VORNADO REALTY TRUST
HIW vs VNO
KILROY REALTY CORP
HIW vs KRC
ALEXANDRIA REAL ESTATE EQUITIES, INC.
HIW vs ARE
Jazz Pharmaceuticals plc
HIW vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
HIW vs SUPN
Intra-Cellular Therapies, Inc.
HIW vs ITCI
ACADIA PHARMACEUTICALS INC
HIW vs ACAD
Vanda Pharmaceuticals Inc.
HIW vs VNDA
LivaNova PLC
HIW vs LIVN
$3.84B
$163.66M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.